This panel discusses several policy aspects regarding the current challenges and implications of the EU Health Technology Assessment (HTA) regulation, covering topics such as the current position of the EU HTA implementation, the major challenges expected from the industry’s viewpoint, the stance of member states and various stakeholders, and strategies for the industry to prepare for joint clinical assessments.
On the topic of systematic literature reviews (SLRs) & indirect treatment comparisons (ITCs), the panel presents and discusses the following technical aspects more in detail:
How will the joint clinical assessment (JCA) process impact the approach needed for SLRs and ITCs, in terms of multiple PICOs for example?
How will OPEN Health leverage its expertise to meet the timelines of JCA submissions in an efficient manner?
For more info, go to: healtheconomics.com/webinar/e...
3 июн 2024
